Targeting SRC in glioblastoma tumors and brain metastases: Rationale and preclinical studies
- 8 December 2010
- journal article
- review article
- Published by Elsevier BV in Cancer Letters
- Vol. 298 (2), 139-149
- https://doi.org/10.1016/j.canlet.2010.08.014
Abstract
No abstract availableKeywords
This publication has 124 references indexed in Scilit:
- Synapse formation regulated by protein tyrosine phosphatase receptor T through interaction with cell adhesion molecules and FynThe EMBO Journal, 2009
- Latent Bone Metastasis in Breast Cancer Tied to Src-Dependent Survival SignalsCancer Cell, 2009
- Dasatinib synergizes with doxorubicin to block growth, migration, and invasion of breast cancer cellsBritish Journal of Cancer, 2009
- Bead-based profiling of tyrosine kinase phosphorylation identifies SRC as a potential target for glioblastoma therapyNature Biotechnology, 2008
- Effects of dasatinib on EphA2 receptor tyrosine kinase activity and downstream signalling in pancreatic cancerBritish Journal of Cancer, 2008
- Comprehensive genomic characterization defines human glioblastoma genes and core pathwaysNature, 2008
- Targeting AMAP1 and cortactin binding bearing an atypical src homology 3/proline interface for prevention of breast cancer invasion and metastasisProceedings of the National Academy of Sciences of the United States of America, 2006
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005
- Dissemination and growth of cancer cells in metastatic sitesNature Reviews Cancer, 2002
- Integrins: Versatility, modulation, and signaling in cell adhesionCell, 1992